Home/Filings/4/0001415889-24-011251
4//SEC Filing

Gillies Hunter 4

Accession 0001415889-24-011251

CIK 0001798749other

Filed

Apr 18, 8:00 PM ET

Accepted

Apr 19, 6:00 PM ET

Size

13.4 KB

Accession

0001415889-24-011251

Insider Transaction Report

Form 4
Period: 2024-04-17
Gillies Hunter
Chief Medical Officer
Transactions
  • Sale

    Common Stock

    2024-04-17$22.30/sh3,689$82,2673,562 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2024-04-173,497539 total
    Exercise: $1.74Exp: 2030-09-03Common Stock (3,497 underlying)
  • Sale

    Common Stock

    2024-04-17$23.33/sh311$7,2553,251 total
  • Exercise/Conversion

    Common Stock

    2024-04-17$1.74/sh+4,000$6,9607,251 total
  • Exercise/Conversion

    Stock Option (Right to Buy)

    2024-04-175032,511 total
    Exercise: $1.74Exp: 2030-09-03Common Stock (503 underlying)
Footnotes (5)
  • [F1]This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on January 19, 2023.
  • [F2]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $22.08 to $22.80, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
  • [F3]The price reported in Column 4 is a weighted average price. The shares were sold in multiple transactions at prices ranging from $23.12 to $23.97, inclusive. Full information regarding the number of shares sold at each separate price can be furnished to the SEC staff upon request.
  • [F4]A total of 24,108 shares subject to an employee stock option were granted on September 4, 2020, with 25% of the shares vested on August 1, 2021, and the remainder vesting in 36 substantially equal monthly installments thereafter.
  • [F5]A total of 16,097 shares subject to an employee stock option were granted on September 4, 2020, with 10% of this option vested on May 1, 2020, 22.5% vested on May 1 2021, and the remainder vesting in 36 substantially equal monthly installments thereafter.

Issuer

Aerovate Therapeutics, Inc.

CIK 0001798749

Entity typeother

Related Parties

1
  • filerCIK 0001868997

Filing Metadata

Form type
4
Filed
Apr 18, 8:00 PM ET
Accepted
Apr 19, 6:00 PM ET
Size
13.4 KB